Skip to main content
Beth Israel Deaconess Medical Center

Szabo Lab

Home
Primary menu
  • Research
    • Alcohol and Monocyte Signaling
    • Innate Immune Signaling Pathways
    • Inflammation in NASH
    • microRNAs
    • Biomarkers
    • Extracellular Vesicles
    • Aging
    • Neuroinflammation and Multi-Organ Damage
    • Gut and Alcohol
    • Clinical Alcohol Hepatitis
  • Publications
  • Funding
  • Team
  • News
  • Contact
  1. Home
  2. Publications
  3. Exosomes and MicroRNA-223 at the Intersection of Inflammation and Fibrosis in NAFLD.

Exosomes and MicroRNA-223 at the Intersection of Inflammation and Fibrosis in NAFLD.

Szabo G. Exosomes and MicroRNA-223 at the Intersection of Inflammation and Fibrosis in NAFLD.. Hepatology (Baltimore, Md.). 2021;74(1):5–8. PMID: 33724502
Publisher's Version
Last updated on 09/19/2024
PubMed

Recent Publications

  • Comprehensive assessment of erenumab efficacy in participants with high-frequency episodic migraine with at least one previously failed preventive treatment: The EMBRACE study.
  • Clinical trial design, biomarkers and end points in metabolic and alcohol-related liver disease.
  • Natural history and development of a novel composite endpoint in patients with alcohol-associated Hepatitis: Data from a prospective multicenter study.
  • Efficacy and Safety of Erenumab in Adults With Medication Overuse Headache: Final Results From a Phase 4 Randomized Placebo-Controlled Study.
  • Ethanol consumption aggravates amyloid pathology and neuroinflammation in Alzheimer's disease associated with inflammasome activation and ASC speck propagation.
  • The efficacy of rosuvastatin to reduce circulating tissue factor extracellular vesicles after ovarian cancer surgery.
More

Szabo Lab

 

Powered byOpenScholar®Admin Login